ARTICLE | Clinical News
CDA: Phase III started
July 31, 2006 7:00 AM UTC
GSK started a double-blind, African Phase III trial in 1,395 patients to compare CDA to malaria drug Coartem artemether/lumefantrine from Novartis AG (NVS; SWX:NOVN, Basel, Switzerland). GSK is devel...